September 5, 2023 NUCLIDIUM to Present Data from Three Clinical-Ready Precision Oncology Programs at the 36th Annual EANM Congress NUCLIDIUM to Present Data from Three Clinical-Ready Precision Oncology Programs at the 36th Annual EANM Congress
May 15, 2023 NUCLIDIUM and PharmaLogic Form Strategic Partnership for Sustainable Development of Novel Copper-based Theranostics NUCLIDIUM and PharmaLogic Form Strategic Partnership for Sustainable Development of Novel Copper-based Theranostics to Diagnose and Treat Solid Tumours
Tags Events / March 21, 2023 NUCLIDIUM at BioEquity & Swiss Biotech Days Our CEO Leila Jaafar will present the company and our unique copper-based approach at the upcoming conferences. Meet us there!